Abiopharma

New Form 8-K - BIOCRYST PHARMACEUTICALS INC Filed: 2025-07-31 AccNo: 0001171843-25-004869 Size: 235 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - AMICUS THERAPEUTICS, INC. Filed: 2025-07-31 AccNo: 0001104659-25-072447 Size: 7 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - TELEFLEX INC Filed: 2025-07-31 AccNo: 0000096943-25-000112 Size: 6 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form DEF 14A - Cadrenal Therapeutics, Inc. Filed: 2025-07-31 AccNo: 0001213900-25-069612 Size: 5 MB

New Form ARS - Cadrenal Therapeutics, Inc. Filed: 2025-07-31 AccNo: 0001213900-25-069619 Size: 3 MB

New Form DEFA14A - Cadrenal Therapeutics, Inc. Filed: 2025-07-31 AccNo: 0001213900-25-069615 Size: 3 MB

New Form 10-Q - Apellis Pharmaceuticals, Inc. Filed: 2025-07-31 AccNo: 0000950170-25-100545 Size: 10 MB

New Form 8-K - AGIOS PHARMACEUTICALS, INC. Filed: 2025-07-31 AccNo: 0001439222-25-000087 Size: 320 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - OMNICELL, INC. Filed: 2025-07-31 AccNo: 0000926326-25-000016 Size: 574 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - COMPASS Pathways plc Filed: 2025-07-31 AccNo: 0001816590-25-000102 Size: 10 MB